Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereafter, yet this is set to end in 2024. Amidst a gradual reduction in valuations and improved balance sheet strength, appeal is getting evident here.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #cervicalcancerscreening--Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System.
With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily, the sector benefits from permanent relevance.
The U.S. fell seven places in an annual global ranking of women's health, landing at 30th place alongside Kazakhstan and Mauritius.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.